NHS ester-PEG4-Val-Cit-PAB-MMAE

NHS ester-PEG4-Val-Cit-PAB-MMAE

NHS ester-PEG4-Val-Cit-PAB-MMAE can be used antibody drug conjugation as a precursor. It contains a PEG4 spacer, a protease-sensitive Val-Cit dipeptide, a PAB linker and an MMAE payload. Please contact us for GMP-grade inquiries.

Molecular structure of the compound BP-25503
    • Unit
    • Price
    • Qty
    • 10 MG
    • $1500.00
    • 25 MG
    • $2800.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Huang, C. H., Chang, E., Zheng, L., Raj, J. G. J., Wu, W., Pisani, L. J., & Daldrup-Link, H. E. (2023). Tumor protease-activated theranostic nanoparticles for MRI-guided glioblastoma therapy. Theranostics, 13(6), 1745–1758. https://doi.org/10.7150/thno.79342
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091873/
  2. Kumru, K., Yao, Z., Holmes, B. B., Zhao, F., Zhang, Y., Ferrara, E., ... & Wells, J. A. (2025). A cytokine receptor-targeting chimera (kineTAC) toolbox for expanding extracellular targeted protein degradation. bioRxiv, 2025-09.
    https://www.biorxiv.org/content/10.1101/2025.09.02.673832v1.full
  3. Njotu, F. N., Garcia, M. D., Nwangele, E., Babeker, H., Ketchemen, J. P., Price, E. W., ... & Fonge, H. Efficacy of a site-specific anti-Nectin-4 antibody-drug conjugate against Nectin-4-positive triple negative breast cancer models. Available at SSRN 5994000.
    https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5994000
  4. Yen-Pang HSU, Sampat L. INGALE. Bisecting-glycan bridged conjugation for producing glycoprotein conjugates. (EP4615513A1)
    https://patents.google.com/patent/EP4615513A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=17
  5. Zhao, F., Wu, Y., Schaefer, K., Zhang, Y., Miao, K., Yao, Z., ... & Wells, J. A. (2025). Hijacking Extracellular Targeted Protein Degrader–Drug Conjugates for Enhanced Drug Delivery. Journal of the American Chemical Society, 147(43), 39912-39925.
    https://pubs.acs.org/doi/full/10.1021/jacs.5c15047
  6. Zhao, F., Wu, Y., Schaefer, K., Zhang, Y., Miao, K., Yao, Z., ... & Wells, J. A. (2025). Low-density lipoprotein receptor-targeting chimeras for membrane protein degradation and enhanced drug delivery. bioRxiv, 2025-06.
    https://www.biorxiv.org/content/10.1101/2025.06.06.658366v1.full